Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide ; volume:72 ; number:8 ; day:24 ; month:4 ; year:2023 ; pages:2865-2871 ; date:8.2023
Cancer immunology immunotherapy ; 72, Heft 8 (24.4.2023), 2865-2871, 8.2023
- Urheber
-
Naoe, Tomoki
Saito, Akiko
Hosono, Nahoko
Kasahara, Senji
Muto, Hideharu
Hatano, Kaoru
Ogura, Mizuki
Masunari, Taro
Tanaka, Masatsugu
Usuki, Kensuke
Ishikawa, Yuichi
Ando, Koji
Kondo, Yukio
Takagi, Yusuke
Takada, Satoru
Ishikawa, Maho
Choi, Ilseung
Sano, Akihiro
Nagai, Hirokazu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-023-03432-4
- URN
-
urn:nbn:de:101:1-2023102609384499084430
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Naoe, Tomoki
- Saito, Akiko
- Hosono, Nahoko
- Kasahara, Senji
- Muto, Hideharu
- Hatano, Kaoru
- Ogura, Mizuki
- Masunari, Taro
- Tanaka, Masatsugu
- Usuki, Kensuke
- Ishikawa, Yuichi
- Ando, Koji
- Kondo, Yukio
- Takagi, Yusuke
- Takada, Satoru
- Ishikawa, Maho
- Choi, Ilseung
- Sano, Akihiro
- Nagai, Hirokazu
- SpringerLink (Online service)
Ähnliche Objekte (12)
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study
Analyse der spenderabhängigen WT1 spezifischen T-Zellexpansion
A role for Wt1 in female fertility
An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia
Der Transkriptionsfaktor Wt1 in Podozyten - eine genomweite ChlPseq Analyse der DNA Bindungsstellen von Wt1 in der Maus
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins
WT1 complete gonadal dysgenesis with membranoproliferative glomerulonephritis: case series and literature review
Expressionsanalyse von WT1 in Hirntumoren : eine retrospektive Studie
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study
Analyse der spenderabhängigen WT1 spezifischen T-Zellexpansion
A role for Wt1 in female fertility
An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia
Der Transkriptionsfaktor Wt1 in Podozyten - eine genomweite ChlPseq Analyse der DNA Bindungsstellen von Wt1 in der Maus
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins
WT1 complete gonadal dysgenesis with membranoproliferative glomerulonephritis: case series and literature review
Expressionsanalyse von WT1 in Hirntumoren : eine retrospektive Studie
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study
Analyse der spenderabhängigen WT1 spezifischen T-Zellexpansion
A role for Wt1 in female fertility
An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia
Der Transkriptionsfaktor Wt1 in Podozyten - eine genomweite ChlPseq Analyse der DNA Bindungsstellen von Wt1 in der Maus
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins
WT1 complete gonadal dysgenesis with membranoproliferative glomerulonephritis: case series and literature review